Characterization of selective and potent PI3Kδ inhibitor (PI3KDIN- 015) for B-Cell malignances.
Liu X, Wang A, Liang X, Chen C, Liu J, Zhao Z, Wu H, Deng Y, Wang L, Wang B, Wu J, Liu F, Fernandes SM, Adamia S, Stone RM, Galinsky IA, Brown JR, Griffin JD, Zhang S, Loh T, Zhang X, Wang W, Weisberg EL, Liu J, Liu Q.
Liu X, et al. Among authors: zhang s, zhang x.
Oncotarget. 2016 May 31;7(22):32641-51. doi: 10.18632/oncotarget.8702.
Oncotarget. 2016.
PMID: 27081697
Free PMC article.